Ekta on Sun Pharma Q1FY20 numbers

Name: Ekta on Sun Pharma Q1FY20 numbers
Uploaded: 2019-08-13T02:30:43+00:00
Duration: 1 min 43 s
Channel: CNBC-TV18
Description: Expect around 10 percent plus growth which would come in on the revenue. EBITDA growth of around 8.5 percent odd with margins stable at around 21-22 percent and profit growth in single digit around 7 percent odd.

CNBC-TV18

Expect around 10 percent plus growth which would come in on the revenue. EBITDA growth of around 8.5 percent odd with margins stable at around 21-22 percent and profit growth in single digit around 7 percent odd.

Featured channels